Is there a link between SARS-CoV-2 infection and diabetes?
Prof. Dirk Homann shares his research at the interface of infectious and autoimmune disease
Prof. Dirk Homann shares his research at the interface of infectious and autoimmune disease
Discover how immunohistochemistry is supporting the identification of molecular subtypes of breast cancer
Dr. Supriya Shivakumar shares how Abcam is striving to provide top quality, fit-for-purpose proteins to the scientific community
The partnership aims to combine oncolytic viruses with Affibody® molecules
AMSBIO launches new additions to its COVID-19 Tools for Research portfolio
Watch this on-demand webinar to learn more about a commercial-scale approach to monoclonal antibody production
Watch this on-demand webinar to learn more about the potential consequences of SARS-CoV-2 mutations and variants for vaccination status and lab testing
Sartorius acquires a majority stake in ALS Automated Lab Solutions
The new assays enable scientists to quickly measure neutralizing antibodies against SARS-CoV-2 virus
Explore the latest technologies, free downloads, and expert insights that can help your laboratory achieve compliance successfully
In this interview, we hear from Minna Mattila on the importance of quality control in the development of IVD immunoassays for disease detection, diagnosis, and monitoring
AMSBIO is offering a customizable service enabling scientists to construct specific biofluids and tissue samples
Find out how unbiased lab product reviews are changing the world of science - and why not get involved yourself?
Both vaccines are highly effective and either one is strongly recommended
Discover insights on topics from lab automation and gene therapy to monoclonal antibodies and clinical diagnostics
Explore the latest research in biopharma from scientific posters presented at the SelectScience Virtual Biopharma Summit 2021
Discover insights on topics from cell line development and cancer research, to preparative HPLC and COVID-19 testing
New preclinical data further supports ability of CM-101 to break the vicious cycle of inflammation and fibrosis in primary sclerosing cholangitis
Discover how Merck KGaA, Darmstadt, Germany is helping to combine scientific innovation and environmental stewardship
Top talks from world-leading scientists and the latest resources in the field are now available on demand
Associate Professor Allan Stensballe discusses the use of autoantibodies in precision medicine and the protein microarray technology enabling his research
We hear from Kevin Entzminger on how Abwiz Bio is developing next-gen antibody therapeutics to help answer fundamental questions in science